Literature DB >> 28450941

Rapidly progressive rhino-orbito-cerebral mucormycosis in a patient with type 2 diabetes: A case report.

Yan-Xia Chen1, Yin-Xi He2, Hong Zhou1, Mian Wang1, Sheng-Ou Su1.   

Abstract

With the ongoing economic development, lifestyle changes and an aging population, diabetes mellitus has be come one of the most prevalent chronic diseases in the world. Rhino-orbito-cerebral (ROC) mucormycosis is a rare, acute and angioinvasive fungal infection that can be fatal. Mucormycosis occurs exclusively in immunocompromised patients with diabetes mellitus and other types of immunodeficiency and has three subtypes: Rhino-maxillary, rhino-orbital and ROC mucormycosis. The present study reported on a case of ROC mucormycosis in a patient with diabetic ketoacidosis. In the present case, the pathogen afflicted all of the above organs, including the left eye, nasal cavity, hard palate and cerebrum.

Entities:  

Keywords:  angioinvasive fungal infection; mucormycosis; type 2 diabetes

Year:  2017        PMID: 28450941      PMCID: PMC5403418          DOI: 10.3892/etm.2017.4074

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  11 in total

1.  A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery.

Authors:  M Ericsson; M Anniko; H Gustafsson; C A Hjalt; R Stenling; A Tärnvik
Journal:  Clin Infect Dis       Date:  1993-04       Impact factor: 9.079

2.  Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report.

Authors:  A A Cagatay; S S Oncü; S S Calangu; T T Yildirmak; H H Ozsüt; H H Eraksoy
Journal:  BMC Infect Dis       Date:  2001-11-23       Impact factor: 3.090

Review 3.  Host cell invasion in mucormycosis: role of iron.

Authors:  Ashraf S Ibrahim
Journal:  Curr Opin Microbiol       Date:  2011-07-30       Impact factor: 7.934

4.  In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

Authors:  Qiu N Sun; Annette W Fothergill; Dora I McCarthy; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole.

Authors:  Young Kyung Yoon; Min Ja Kim; Yong Gu Chung; Il Young Shin
Journal:  J Korean Neurosurg Soc       Date:  2010-01-31

Review 6.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.

Authors:  M A Pfaller; S A Messer; R J Hollis; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 8.  Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.

Authors:  Jeffrey M Rybak; Kayleigh R Marx; Andrew T Nishimoto; P David Rogers
Journal:  Pharmacotherapy       Date:  2015-11-02       Impact factor: 4.705

9.  The iron chelator deferasirox protects mice from mucormycosis through iron starvation.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebermariam; Yue Fu; Lin Lin; Mohamed I Husseiny; Samuel W French; Julie Schwartz; Christopher D Skory; John E Edwards; Brad J Spellberg
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.

Authors:  R Y Chinn; R D Diamond
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more
  1 in total

Review 1.  COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression.

Authors:  Tahani Tabassum; Yusha Araf; Abu Tayab Moin; Tanjim Ishraq Rahaman; Mohammad Jakir Hosen
Journal:  Mol Biol Rep       Date:  2021-10-28       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.